Articles tagged with Analgesics
A nationwide survey found that 54% of NSAID users were unaware of potential side effects, and 18% had previously experienced complications. The study emphasizes the need for patient and physician education to prevent unnecessary complications from painkiller misuse.
A meta-analysis of over 95,000 patients found that aspirin significantly reduces the risk of stroke in women, with a 17% reduction in ischemic stroke and a 24% reduction in hemorrhagic stroke. In contrast, aspirin has no protective effect in men and may even increase the risk of bleeding strokes.
The study found that taking aspirin reduced the risk of cardiovascular death and death from all causes in postmenopausal women with cardiovascular disease. Women taking 81mg or 325mg of aspirin showed a significant reduction in mortality rates, with no difference between the two doses.
A new analysis by Duke University Medical Center cardiologists found that low-dose aspirin (81 mg a day) significantly reduces death rates for postmenopausal women with heart disease, similar to higher dose aspirin (325 mg). Fewer than half of the 8,928 women in the study were taking any aspirin.
A Stanford study found that only 33% of high-risk patients received aspirin therapy in 2003, despite conclusive evidence of its benefits. Meanwhile, physicians are increasingly prioritizing pricey statins over aspirin due to heavy marketing.
A study of 173 children aged 2-16 years found that fentanyl patches improved subjective pain and quality of life. The patches were well-tolerated with no significant adverse effects compared to adults, making them a suitable option for managing chronic severe pain in pediatric patients.
Researchers found that only a third of high-risk patients were prescribed aspirin in 2003, despite its cost-effectiveness and recommended use for people with diabetes. The study suggests that physicians prioritize statins over aspirin due to advertising and preference.
High doses of COX-2 inhibitors and other NSAIDs are associated with a higher risk of death, according to the study. Patients taking high doses of celecoxib or rofecoxib were found to be at a strikingly higher risk of death compared to those not taking NSAIDs.
A new drug, clopidogrel, has been shown to significantly reduce deaths from heart attacks, with a 9% decrease in mortality rates compared to placebo. The treatment also resulted in a 14% reduction in repeat heart attacks during the study period, highlighting its potential to save thousands of lives each year.
A recent study found that even healthy people taking high doses of ibuprofen are at risk of internal bleeding, with blood loss ranging from 40mL to 299mL. The research highlights the need for caution when using ibuprofen, particularly in older adults and those with debilitating conditions.
Researchers found that patients taking non-steroidal anti-inflammatory drugs (NSAIDs) and aspirin were more likely to experience serious gastrointestinal problems such as ulcers, perforations, or bleeding. The risk of GI problems was significantly increased when combining NSAIDs with aspirin.
The UK has seen a continued reduction in drug-related deaths, with 73% of all deaths occurring among those under 45. Opiate-related fatalities accounted for the majority (68%) of fatalities in 2004, despite a decrease in the number of deaths involving heroin/morphine.
A study found that anxiety, blood pressure readings and responses to a heat test before surgery can predict post-surgical pain severity and medication requirements. The researchers identified six groups of predictive factors accounting for 90% of the total variances in patients' pain levels.
A study of Norwegian medical students found that nearly 70% self-prescribed medication in their first year after graduation, a trend that continued into their fourth and ninth years. The most commonly self-prescribed medications were antibiotics, contraceptives, and analgesics.
A University of Michigan Health System study found that pharmacies in predominantly minority and low-income areas have lower availability of opioid analgesic pain medications. The gap is pronounced, with 86.9% of white ZIP code pharmacies carrying sufficient supplies compared to 54.2% in minority ZIP codes.
Researchers at the University of Virginia Health System have identified a new type of pain-sensing neuron in rats, which may serve as a target for future therapies to treat neuropathic pain. The T-type calcium channels in these cells may act as a volume control for pain impulses.
A study by Rice University researchers found that salicylate causes membranes to thin, soften, and rupture more easily, increasing the risk of hearing loss. The findings provide a mechanistic basis for the debilitating side effects of anti-inflammatory drugs like aspirin and ibuprofen.
Researchers found that women who labored between noon and 6 p.m. received an average of 27 percent longer pain relief from a single dose of spinal-epidural medication fentanyl compared to those who labored between 8 p.m. and 2 a.m.
A large analysis of Medicare records suggests that aspirin is not harmful and may even lower mortality rates in patients with heart failure and coronary artery disease. However, the debate remains controversial, with some experts recommending limiting or avoiding aspirin use for these patients.
Researchers found abatacept to be effective in treating rheumatoid arthritis, improving at least 20% of patients' condition compared to placebo. The drug reduces immune system attack on joints, providing significant pain relief and improving functionality.
Researchers found that a decline in prostacyclin led to cardiac complications, including hypertension and heart scarring, in mice prone to high blood pressure. Aspirin may protect against this damage by blocking unrestrained thromboxane actions.
A new study found that mice with high blood pressure are more susceptible to cardiac complications when taking painkillers due to a chemical imbalance between prostacyclin and thromboxane. This imbalance can lead to hypertension, enlarged hearts, and severe scarring of the heart.
The ELISA II trial found that triple antiplatelet (AP) therapy reduced enzymatic infarct size and improved epicardial coronary artery flow in patients with non-ST segment elevation acute coronary syndrome (NSTE ACS). Triple AP therapy also showed a trend towards better event-free survival at 96 hours and 30 days after randomization.
The ACTIVE trial program was designed to evaluate the use of clopidogrel plus aspirin in patients with atrial fibrillation. After an interim analysis, it was recommended to discontinue the ACTIVE W trial but continue the ACTIVE A and I trials.
A Dutch study found that end-of-life decisions for children are common, involving medical professionals and families. The study's findings emphasize the need for clear communication about end-of-life care for minors.
Scientists at Monell Chemical Senses Center discovered a natural anti-inflammatory compound, oleocanthal, in olive oil. Oleocanthal inhibits COX enzymes, sharing similar action as ibuprofen, and may play a causal role in health benefits associated with Mediterranean diet.
Researchers found that IP 751 significantly suppressed bladder overactivity without affecting contractility, offering a new option for IC treatment. The study's results are promising for patients with interstitial cystitis, a chronic pelvic pain disorder affecting millions of Americans.
A new study provides direct evidence that the brain's own pain-fighting chemicals play a role in the placebo effect, reducing feelings of pain. Participants who received a sham pain treatment reported increased activity in their mu opioid endorphin system after being told they were receiving a medicine.
A study found that long-term aspirin use lowers the risk of invasive colorectal cancer, especially in those taking high doses for more than 10 years. However, serious gastrointestinal bleeding risk increases with higher doses.
Long-term and regular aspirin use is associated with a significant reduction in colorectal cancer risk, with benefits observed at doses of 14 tablets per week or more. The study found that the risk of colorectal cancer decreased by up to 53% among women who took high-dose aspirin for over 10 years.
A new epidemiological study from the University of Pennsylvania School of Medicine found a protective relationship between non-aspirin, non-steroidal drugs (NANSAIDs) and heart attacks. The study used patient surveys instead of administrative databases, which may have skewed previous results.
A study of over 4,000 women found that taking high doses of acetaminophen and ibuprofen may increase the risk of developing high blood pressure. Women taking these painkillers were more likely to develop hypertension compared to those who didn't use them.
A recent study found that certain drugs, such as sulfonylureas and acetaminophen, may counteract nitroglycerin's effects, increasing cardiovascular risk. The researchers discovered that a specific mitochondrial enzyme, aldehyde dehydrogenase, is crucial for nitroglycerin action.
A study of 372 community-dwelling older patients found that those receiving high-quality care had better survival rates than those without it. The research created a quality-of-care score based on 236 process-of-care measures, with survival improving steadily as the score increased.
Research reveals that aspirin resistance is a significant concern for certain patient groups, particularly those with coronary heart disease or high cholesterol levels. An alternative treatment option, Clopidogrel, has shown promise in reducing blood clotting and inflammation in these patients.
The company will use the investment to accelerate its drug development program for neuropathic pain, a prevalent condition affecting an estimated 45% of diabetics and 75% of those over 70. With a significant worldwide market valued at US$3 billion, Spinifex aims to deliver a novel solution to this unmet medical need.
Researchers at Case Western Reserve University found that taking ibuprofen before gum surgery can lead to nearly double the amount of blood loss compared to those who don't take the medication. The study suggests patients should avoid NSAIDs before oral surgeries to minimize bleeding risk.
A new report describes a potential problem with the new drug pregabalin, which may result in neurological complications such as nausea, headache, and hallucinations. The researchers recommend that patients not stop taking the medication abruptly until further studies are conducted.
A large-scale randomized trial found that low-dose aspirin had no effect on reducing the risk of total cancer, breast cancer, or colorectal cancer in healthy women. The study also suggested a possible trend toward reduced lung cancer risk, but this finding was not statistically significant.
A recent study by the University of Florida found that fentanyl patch abuse led to the death of 115 people in Florida last year. The abuse often involves removing the full dose from the patch and taking it all at once, either through injection, ingestion, or smoking.
A study published in Arthritis & Rheumatism found that doxycycline slowed joint space narrowing by 40-33% compared to a placebo. While it didn't reduce joint pain severity, it did decrease frequent increases in knee pain. The treatment was well-tolerated with minimal side effects.
Researchers have discovered that naturally occurring cannabinoids, such as 2-AG, play a role in stress-induced analgesia. A new drug targeting the enzyme monoacylglycerol lipase could manipulate these compounds to provide pain relief without psychoactive side effects.
Researchers have discovered a link between stress-induced analgesia and endocannabinoids, finding that natural marijuana-like chemicals in the brain play a key role in pain suppression. A novel inhibitor molecule has been developed to boost the analgesic effect of the specific cannabinoid compound most directly related to pain relief.
Researchers found that placebo treatment reduced subjects' ratings of unpleasant pictures and activity in emotional centers. The study generalizes the concept of placebo effect and its underlying neural mechanisms for both pain perception and emotional stimuli.
Researchers developed a drug cocktail combining morphine with methadone to prevent cellular signaling imbalances associated with opiate tolerance. The study found that rats receiving the cocktail experienced reduced morphine dependence, suggesting a potential approach for treating chronic pain.
Scientists develop gene transfer technology to block neuropathic pain by delivering a GABA-enhancing gene via a disabled herpes simplex virus. The treatment showed promise in animal studies, with pain-relieving effects lasting up to six weeks. A clinical trial in humans is planned.
A new study found that long-term daily use of aspirin was associated with an increased risk of ER/PR-negative breast cancer, while long-term daily use of ibuprofen was linked to a higher risk of nonlocalized breast cancer. Regular NSAID use was not associated with breast cancer risk.
Scientists Tiruppattur V. Ramakrishnan and Sergio Henrique Ferreira receive the first Trieste Science Prizes for their groundbreaking research in physics and biological sciences. Their work has led to significant breakthroughs in understanding quantum transport, nanoscopic systems, and the treatment of hypertension and chronic pain.
A study finds that opioid medications are safe and effective for long-term pain relief in older patients, but pose risks for younger patients. Older patients experience significant relief with minimal dose escalation, while younger patients show no long-term benefit despite high doses.
Researchers at UF found dextromethorphan, commonly used in cough remedies, reduces fibromyalgia 'wind-up' pain. The study suggests the drug may eventually be an option for treating fibromyalgia and other conditions involving heightened pain sensitivity.
A new understanding of morphine's side effects has been gained through the discovery of methylnaltrexone, a peripheral opiate antagonist. This breakthrough allows scientists to distinguish between morphine's central analgesic and peripheral side effects, offering new hope for patients experiencing severe nausea, itching, and constipation.
A prospective study of 846 patients with stage III colon cancer found that regular aspirin use reduced the risk of recurrence by 55% and mortality by 48%. COX-2 inhibitors showed similar benefits, with no effect seen from acetaminophen use.
Researchers studied brain activity in fibromyalgia patients to understand depression-pain connection. They found heightened sensitivity to pressure-induced pain in FM patients, regardless of depressive symptoms. The study suggests treating depression and physical pain separately for better outcomes.
Research suggests that daily acetaminophen use is associated with a higher prevalence of asthma and chronic obstructive pulmonary disease (COPD), as well as decreased lung function. In contrast, vitamin C supplementation during pregnancy can limit the negative effects of nicotine on fetal lung tissue.
A population-based study found that long-term NSAID use significantly reduced the risk of developing oral cancer in light to moderate smokers, with a 65% decrease observed compared to non-NSAID users. The most effective NSAIDs were those used by smokers with low pack-year tobacco consumption.
A recent study published by the American Academy of Neurology suggests that long-term use of ibuprofen may lower the risk of developing Parkinson's disease. The research found a 35% lower risk among ibuprofen users compared to non-users, with risks decreasing depending on weekly dosage.
Researchers found that pretreating with DHE can prevent migraines from progressing to debilitating sensitization. This breakthrough suggests that more patients can benefit from standard treatment using intravenous DHE.
A new study published in Arthritis & Rheumatism found that Pfizer's Lyrica significantly reduced pain and improved sleep, fatigue, and other symptoms in patients with fibromyalgia. The study also showed a clinically meaningful reduction of pain in 48% of patients taking Lyrica compared to 27% on placebo.
Researchers developed patient scenarios to compare costs of three therapies for treating chronic arthritis pain. The study found that combining a non-steroidal anti-inflammatory drug with an acid-reducing drug was less expensive, safer, and more effective than using a Cox-2 inhibitor alone.
A study found that 57% of end-of-life decisions in neonates and infants involve withdrawing or withholding treatment, with lethal doses administered in 9 cases. Doctors support legalizing termination in some cases due to the expected poor quality of life and lack of survival chances.